These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8326956)

  • 21. A retrospective analysis of biofilm antibiotic susceptibility testing: a better predictor of clinical response in cystic fibrosis exacerbations.
    Keays T; Ferris W; Vandemheen KL; Chan F; Yeung SW; Mah TF; Ramotar K; Saginur R; Aaron SD
    J Cyst Fibros; 2009 Mar; 8(2):122-7. PubMed ID: 19064337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mucoviscidosis--cystic fibrosis. Diagnosis--therapy--prognosis].
    Posselt HG
    Z Arztl Fortbild Qualitatssich; 1997 Jun; 91(3):243-9. PubMed ID: 9312429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bacterial infections and resistance to antibiotics in cystic fibrosis].
    Taccetti G; Repetto T; Procopio E; Marianelli L; Campana S
    Pediatr Med Chir; 1999; 21(5 Suppl):213-8. PubMed ID: 10963010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function.
    Ren CL; Morgan WJ; Konstan MW; Schechter MS; Wagener JS; Fisher KA; Regelmann WE;
    Pediatr Pulmonol; 2007 Jun; 42(6):513-8. PubMed ID: 17469151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cystic fibrosis--review].
    Jonsdottir B; Bergsteinsson H; Baldursson O
    Laeknabladid; 2008 Dec; 94(12):831-7. PubMed ID: 19182319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term benefits of inhaled tobramycin in children with cystic fibrosis: first clinical observations from Poland.
    Stelmach I; Korzeniewska A; Stelmach W
    Respiration; 2008; 75(2):178-81. PubMed ID: 17435382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anti Pseudomonas aeruginosa antibiotic therapy in cystic fibrosis (exclusion of macrolides)].
    Sermet-Gaudelus I; Ferroni A; Vrielinck S; Lebourgeois M; Chedevergne F; Lenoir G
    Arch Pediatr; 2006 Oct; 13 Suppl 1():S30-43. PubMed ID: 17370394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cystic fibrosis: current therapy. Antibiotics].
    Tamm M; Héritier F; Rappaz I; Schaad UB
    Schweiz Med Wochenschr Suppl; 2000; 122():33S-37S. PubMed ID: 12536469
    [No Abstract]   [Full Text] [Related]  

  • 29. Management problems of the adult with cystic fibrosis.
    Webb AK
    Schweiz Med Wochenschr; 1991 Jan; 121(4):110-4. PubMed ID: 1706111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosing and managing infection in CF.
    Ratjen F
    Paediatr Respir Rev; 2006; 7 Suppl 1():S151-3. PubMed ID: 16798546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cystic fibrosis: nutritional considerations].
    Molina Arias M; Prieto Bozano G; Sarría Osés J; Polanco Allué I
    An Esp Pediatr; 2001 Jun; 54(6):575-81. PubMed ID: 11412406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of the child with cystic fibrosis.
    Byrne S; David TJ
    Br J Hosp Med; 1993 Oct 20-Nov 2; 50(8):445-51. PubMed ID: 8275282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.
    Emerson J; Rosenfeld M; McNamara S; Ramsey B; Gibson RL
    Pediatr Pulmonol; 2002 Aug; 34(2):91-100. PubMed ID: 12112774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcome of lung transplantation for cystic fibrosis--Danish results.
    Bech B; Pressler T; Iversen M; Carlsen J; Milman N; Eliasen K; Perko M; Arendrup H
    Eur J Cardiothorac Surg; 2004 Dec; 26(6):1180-6. PubMed ID: 15541981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Rehabilitation of cystic fibrosis in adulthood].
    Leser C; Rothe TB; Karrer WL
    Praxis (Bern 1994); 1997 Dec; 86(50):1984-90. PubMed ID: 9465725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temocillin in cystic fibrosis: a retrospective pilot study.
    Kent L; Bradley JM; France M; Döring G; Carryn S; Bradbury I; Rendall J; Jones A; Elborn JS
    J Cyst Fibros; 2008 Nov; 7(6):551-4. PubMed ID: 18706868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute renal failure in cystic fibrosis: association with inhaled tobramycin therapy.
    Hoffmann IM; Rubin BK; Iskandar SS; Schechter MS; Nagaraj SK; Bitzan MM
    Pediatr Pulmonol; 2002 Nov; 34(5):375-7. PubMed ID: 12357482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rifampicin and sodium fusidate reduces the frequency of methicillin-resistant Staphylococcus aureus (MRSA) isolation in adults with cystic fibrosis and chronic MRSA infection.
    Garske LA; Kidd TJ; Gan R; Bunting JP; Franks CA; Coulter C; Masel PJ; Bell SC
    J Hosp Infect; 2004 Mar; 56(3):208-14. PubMed ID: 15003669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cystic fibrosis: paediatric aspects.
    Wallis C
    Br J Hosp Med; 1996 Mar 6-19; 55(5):241-7. PubMed ID: 8777514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chronic obstructive bronchopneumopathy with evolutive character in cystic fibrosis].
    Rigillo N; Masciale A; Manca A
    Arch Monaldi Mal Torace; 1989; 44(1-3):277-85. PubMed ID: 2520575
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.